Bryan Heart

Lincoln, Nebraska 68510

10 studies enrolling now · 39 studies all time

What they study most

Acute Kidney Injury, Acute Myocardial Infarction, Advanced Heart Failure, Aneurysm of Ascending Aorta, Anticipatory Guidance, Aortic Stenosis, Aortic Valve Disorder, Aortic Valve Stenosis, Arterial Embolism, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Atrial Fibrillation New Onset

Studies at this site

• OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
• Assessment of CCM in HF With Higher Ejection Fraction — Recruiting now
• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
• A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events — Recruiting now
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
• Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool — Recruiting now
• Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement — Recruiting now
• Abbott Vascular Medical Device Registry — Recruiting now
• TECTONIC CAD IVL IDE Study — Running, not enrolling
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Aveir DR i2i Study — Completed
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
• XIENCE Skypoint Large Vessel Post Approval Study — Running, not enrolling
• Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
• Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity — Completed
• Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes — Completed
• A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
• Amulet™ ADVANCE LAA — Running, not enrolling
• STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation — Completed
• Benefits of Microcor in Ambulatory Decompensated Heart Failure — Completed
• Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery — Stopped early
• Repository of Phase Signals for Pulmonary Hypertension Algorithm Development — Status unconfirmed
• Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis — Status unconfirmed
• ECG Belt for CRT Response — Completed
• Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation — Completed
• QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding — Completed
• Tachy Prediction Download Study — Completed
• QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery — Stopped early
• Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass — Status unconfirmed
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed
• Self-Management App for Patients With Left-Ventricular Assist Devices — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Respicardia, Inc. Pivotal Trial of the remedē System — Completed
• Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients — Stopped early
• Progel Vascular Sealant — Completed